US Patent Issued to The Brigham and Women's Hospital on June 3 for "Methods for identifying progression of a primary melanoma" (Massachusetts Inventor)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,970, issued on June 3, was assigned to The Brigham and Women's Hospital Inc. (Boston).

"Methods for identifying progression of a primary melanoma" was invented by Thomas S. Kupper (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of using T cell frequency (TCFR) in melanoma, e.g., as determined by high throughput DNA sequencing of the TCRB gene, as a predictor of disease progression and survival in patients with primary melanoma, and to select and treat subjects."

The patent was filed on Sept. 29, 2022, under Application No. 17/956,050.

*For further information, including images, charts and tables, please visit: http://patft.us...